Nyxoah SA (FRA:5YI)

Germany flag Germany · Delayed Price · Currency is EUR
4.080
+0.070 (1.75%)
Last updated: Dec 5, 2025, 9:59 AM CET
-44.57%
Market Cap 184.15M
Revenue (ttm) 5.64M
Net Income (ttm) -83.72M
Shares Out n/a
EPS (ttm) -2.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 1,222
Open 3.925
Previous Close 4.010
Day's Range 3.925 - 4.080
52-Week Range 3.660 - 10.700
Beta n/a
RSI 48.78
Earnings Date Mar 13, 2026

About Nyxoah

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2009
Employees 184
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5YI
Full Company Profile

Financial Performance

In 2024, Nyxoah's revenue was 4.52 million, an increase of 3.98% compared to the previous year's 4.35 million. Losses were -59.24 million, 37.1% more than in 2023.

Financial Statements

News

There is no news available yet.